WordNet

a substance that exerts some force or effect
a businessman who buys or sells for another in exchange for a commission (同)factor, broker
any agent or representative of a federal agency or bureau (同)federal agent
a representative who acts on behalf of other persons or organizations
an active and efficient cause; capable of producing a certain effect; "their research uncovered new disease agents"
drug that has the effects of epinephrine (同)adrenergic_drug
relating to epinephrine (its release or action) (同)sympathomimetic

PrepTutorEJDIC

出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2014/05/09 14:44:38」(JST)

Adrenergic means "having to do with adrenaline (epinephrine) or noradrenaline (norepinephrine)".^[1]^[2]

For instance, regarding proteins:

And, regarding drugs:

^ Keith Parker; Laurence Brunton; Goodman, Louis Sanford; Lazo, John S.; Gilman, Alfred (2006). Goodman & Gilman's The Pharmacological Basis of Therapeutics (11 ed.). New York: McGraw-Hill. ISBN 0-07-142280-3.
^ Thomas L. Lemke, David A. Williams, ed. (2007). Foye's Principles of Medicinal Chemistry (6 ed.). Baltimore: Lippincott Willams & Wilkins. ISBN 0-7817-6879-9.

This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it.

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 前立腺肥大症の内科的治療 medical treatment of benign prostatic hyperplasia
2. 昇圧剤および強心剤の使用 use of vasopressors and inotropes
3. 抗腫瘍療法関連肺毒性：細胞傷害性薬物 pulmonary toxicity associated with antineoplastic therapy cytotoxic agents
4. 手術室以外で成人に迅速導入気管挿管する際の前投薬 pretreatment medications for rapid sequence intubation in adults outside the operating room
5. 小児における膀胱機能障害のマネージメント management of bladder dysfunction in children

The role of levosimendan in acute heart failure complicating acute coronary syndrome: A review and expert consensus opinion.

Nieminen MS1, Buerke M2, Cohen-Solál A3, Costa S4, Édes I5, Erlikh A6, Franco F4, Gibson C7, Gorjup V8, Guarracino F9, Gustafsson F10, Harjola VP11, Husebye T12, Karason K13, Katsytadze I14, Kaul S15, Kivikko M16, Marenzi G17, Masip J18, Matskeplishvili S19, Mebazaa A20, Møller JE21, Nessler J22, Nessler B23, Ntalianis A24, Oliva F25, Pichler-Cetin E26, Põder P27, Recio-Mayoral A28, Rex S29, Rokyta R30, Strasser RH31, Zima E32, Pollesello P16.
International journal of cardiology.Int J Cardiol.2016 Sep 1;218:150-7. doi: 10.1016/j.ijcard.2016.05.009. Epub 2016 May 14.
Acute heart failure and/or cardiogenic shock are frequently triggered by ischemic coronary events. Yet, there is a paucity of randomized data on the management of patients with heart failure complicating acute coronary syndrome, as acute coronary syndrome and cardiogenic shock have frequently been d
PMID 27232927

Harris JR1, Hale GM2, Dasari TW3, Schwier NC4.
Journal of cardiovascular pharmacology and therapeutics.J Cardiovasc Pharmacol Ther.2016 Sep;21(5):439-51. doi: 10.1177/1074248416640161. Epub 2016 Apr 13.
Vasospastic angina is a diagnosis of exclusion that manifests with signs and symptoms, which overlap with obstructive coronary artery disease, most often ST-segment elevation myocardial infarction. The pharmacotherapy that is available to treat vasospastic angina can help ameliorate angina symptoms.
PMID 27081186

Stanojcic M1, Finnerty CC, Jeschke MG.
Current opinion in critical care.Curr Opin Crit Care.2016 Aug;22(4):325-31. doi: 10.1097/MCC.0000000000000330.
PURPOSE OF REVIEW: A complex network of hormones and other effectors characterize the hypermetabolic response in critical illness; these mediators work together to induce numerous pathophysiologic alterations. Increased incidence of infection, multiorgan failure, long-term debilitation, delays in re
PMID 27272101